< Back to all Team Members

Moon J. Fenton, MD, PhD

Medical Oncologist and Hematologist
Specialty Area
Cancer Type
Team Role
Primary Location
1588 Union Avenue
Memphis, TN 38104
Phone: 901.683.0055

Moon J. Fenton, MD, PhD, is a Medical Oncologist and Hematologist at West Cancer Center.

Titles and Roles

  • Medical Oncologist/Hematologist, West Cancer Center
  • Associate professor, University of Tennessee Health Science Center
  • Physician Operation Committee, West Cancer Center
  • National Comprehensive Cancer Network (NCCN) guidelines committee on Colorectal Cancer

Areas of Expertise

  • Principal investigator for head and neck cancer research
  • Sub Investigator for upper aerodigestive tract cancer research
  • NCCN guidelines member on colorectal cancer

Biography

Dr. Fenton is board-certified in Internal Medicine, Medical Oncology, and Hematology.  She has a wide interest, receiving her PhD studying cell signal transduction pathways in platelets and successfully publishing several high-impact articles.  During her oncology fellowship training, she focused her research in developing immunotherapeutic options, targeting acute myelogenous leukemia cells.  Furthermore, her interest in genitourinary cancers led to institutional research in prostate cancer and a co-authorship in a book chapter on kidney cancer.  Dr. Fenton received several pre-doctoral awards from the American Society of Hematology and the American Society of Cell Biology.

Currently, she is involved in treating head and neck cancer patients in multidisciplinary setting and works closely with otolaryngologists and radiation oncologist.  She serves as a principal investigator in all head and neck cancer research at West Cancer Center.  In addition, she has a special interest and treats patients with lung and esophageal cancers and works closely with surgeons and radiation physicians to provide optimal, state-of-the art care, while serving as a principal investigator and a sub investigator in many of the thoracic cancer research.  Dr. Fenton also currently sits on the National Comprehensive Care Network® (NCCN) panel for colorectal cancer, and is involved in development of community-wide treatment pathways and recommendations to treat colorectal cancers patients here in the Mid-South.

Dr. Fenton’s husband serves as an attending physician in Emergency Medicine at a local hospital.  She enjoys spending time with her family including twin daughters and two dogs.

Education and Training

Dr. Fenton attended undergraduate school at the University of Tennessee in Knoxville. She went on to receive a PhD in Molecular Cell Sciences at The University of Memphis, in conjunction with research at St. Jude Children’s Research Hospital for four years in the Department of Experimental Hematology, studying cell signal transduction pathways in platelets. Upon receiving her doctoral degree, Dr. Fenton attended Medical School at the University of Tennessee Health Science Center. She completed her Residency in Internal Medicine at Wayne State University, where she was named Intern of the Year and Most Outstanding Resident in the Outpatient Clinic. After finishing her Residency training, Dr. Fenton completed a Fellowship in Hematology-Oncology at the University of Pittsburgh Medical Center.

Awards

  • Most Outstanding Resident in Outpatient Clinic, Wayne State University, 2009
  • Intern of the Year, Wayne State University, 2007
  • American Society of Cell Biology Predoctoral Student Award, 2001
  • American Society of Hematology Predoctoral Student Award, 2001
  • Graduate Student Research Forum, First Place, Univ. of Memphis, 2000
  • Graduate Student Research Forum, First Place, Univ. of Memphis, 1999

Research

Dr. Fenton has been involved with research throughout her whole educational career. Currently, she is focusing on:

  • Human papillomavirus-related oropharyngeal cancer treatment options to minimize toxicities of cancer therapy in patients undergoing curative treatments
  • Immunotherapies targeting and stimulating a patient’s immune system to help fight head and neck cancers who have recurrent or metastatic disease
  • Targeted therapies against certain mutations in patients with specific protein mutations in lung cancers

Publications

Dr. Fenton has been published many times, appearing in Blood, Case Reports in Surgery, and Oncology Research.  

To view Dr. Fenton’s most recent publications, click here.